Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.09
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.09), versus $0.02 reported last year. Revenue for the quarter came in at $8.6 million, versus $9.6 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
